Suspended

Outcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation

What is being collected

Data Collection

Collected from past medical records and data - Retrospective

Who is being recruted

Pathologic Processes

+ Shock

+ Pathological Conditions, Signs and Symptoms

+2 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.

Observational

Study Start: January 2019

See protocol details

Summary

Principal SponsorSoutheast University, China

Study ContactLing Liu, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: January 30, 2019

Actual date on which the first participant was enrolled.

Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2011 to March 1,2017 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expected mortality) and related treatment conditions(duration of ICU stay, duration of ECMO,duration of mechanical ventilation,ventilation conditions,prone ventilation,ECMO complications )will be used to assess the severity and curative effect of these patients.Short Form-36 Health Status Questionnaire,EuroQol-5 Dimensions and St. George's Respiratory Questionnaire(SGRQ) will deliver in these survivors ,which are used to assess the physical and mental health ,as well as the social adaptation. Finally a comprehensive assessment will be obtained to describe the outcomes and long-term quality-of-life of patients treated With ECMO.

Official TitleOutcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation

NCT03182023

Principal SponsorSoutheast University, China

Study ContactLing Liu, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

83 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Pathologic ProcessesShockPathological Conditions, Signs and Symptoms

Criteria

1 inclusion criteria required to participate

patients treated with ECMO

1 exclusion criteria prevent from participating

non-survivors of patients treated with ECMO，declined or lost to follow up

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Nanjing Zhong-Da Hospital, Southeast University

Nanjing, ChinaOpen Nanjing Zhong-Da Hospital, Southeast University in Google Maps

SuspendedOne Study Center